---
figid: PMC10148080__gr4
figtitle: NAT10 as ac4C writer in diseases
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10148080
filename: gr4.jpg
figlink: /pmc/articles/PMC10148080/figure/fig4/
number: F4
caption: The mechanism of NAT10 in hematological malignanciesIn AML, NAT10 influences
  the cell cycle by increasing the expression of p16 and p21 through cyclins like
  CDK2, CDK4, cyclin D1, and cyclin E; NAT10 causes endoplasmic reticulum stress,
  activates Bim and PUMA, interferes the Bax/Bcl-2-caspase-3/9 pathway, and promotes
  apoptosis. In MM, NAT10 influences CEP170 mRNA ac4C to enhance proliferation, and
  stimulates the PI3K-AKT-Bcl-xl-Bax pathway to alter the cell cycle.
papertitle: Mechanisms of NAT10 as ac4C writer in diseases.
reftext: Lihua Xie, et al. Mol Ther Nucleic Acids. 2023 Jun 13;32:359-368.
year: '2023'
doi: 10.1016/j.omtn.2023.03.023
journal_title: Molecular Therapy. Nucleic Acids
journal_nlm_ta: Mol Ther Nucleic Acids
publisher_name: American Society of Gene & Cell Therapy
keywords: 'MT: RNA/DNA Editing | NAT10 | ac4C | acetyltransferase | writer | RNA modification'
automl_pathway: 0.9511387
figid_alias: PMC10148080__F4
figtype: Figure
redirect_from: /figures/PMC10148080__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10148080__gr4.html
  '@type': Dataset
  description: The mechanism of NAT10 in hematological malignanciesIn AML, NAT10 influences
    the cell cycle by increasing the expression of p16 and p21 through cyclins like
    CDK2, CDK4, cyclin D1, and cyclin E; NAT10 causes endoplasmic reticulum stress,
    activates Bim and PUMA, interferes the Bax/Bcl-2-caspase-3/9 pathway, and promotes
    apoptosis. In MM, NAT10 influences CEP170 mRNA ac4C to enhance proliferation,
    and stimulates the PI3K-AKT-Bcl-xl-Bax pathway to alter the cell cycle.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NAT10
  - CDK2
  - CCND1
  - CCNE1
  - CCNE2
  - CDK4
  - AKT1
  - AKT2
  - AKT3
  - BCL2L11
  - BBC3
  - CEP170
  - CDKN2A
  - H3P10
  - BAX
  - BCL2
  - CHMP2A
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - WARS1
  - Acute myeloid leukemia
  - AML
  - Multiple myeloma
  - leukemia
---
